Abstract
Six cases ofFlavimonas oryzihabitans infection are presented, four of which were community-acquired pneumonia and two of which were nosocomially acquired bacteremia. All four cases of pneumonia occurred in immunosuppressed hosts, three of whom were HIV-positive individuals and one of whom was a young man affected by chronic myeloid leukemia.Flavimonas oryzihabitans is recognized with increasing frequency as a cause of opportunistic infection, but the present cases of community-acquired pneumonia due to this organism are believed to be the first four reported in the English literature. The findings emphasize thatFlavimonas oryzihabitans should be included in the list of pathogens that cause community-acquired infections in the immunocompromised host.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Holmes B, Steigerwalt AG, Weaver RE, Brenner DJ:Chryseomonas luteola comb. nov. andFlavimonas oryzihabitans gen. nov., comb. nov.,Pseudomonas-like species from human clinical specimens and formerly known, respectively, as groups Ve-1 and Ve-2. International Journal of Systematic Bacteriology (1987) 37:245–250
Esteban J, Valero-Moratalla ML, Alcazar R, Soriano F: Infections due toFlavimonas oryzihabitans: case report and literature review. European Journal of Clinical Microbiology & Infectious Diseases (1993) 12:797–800
Pien FD, Chung EYS: Group Ve infection: case report of group Ve-2 septicemia and literature review. Diagnostic Microbiology and Infectious Disease (1986) 5:177–180
Kostman JR, Solomon F, Fekete T: Infections withChryseomonas luteola (CDC group Ve-1) andFlavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Reviews of Infectious Diseases (1991) 13:233–236
Hawkins RE, Moriarty RA, Lewis DE, Oldfield EC: Serious infection involving the CDC group Ve bacteriaChryseomonas luteola andFlavimonas oryzihabitans. Reviews of Infectious Diseases (1991) 13:257–260
Decker CF, Simon GL, Keiser JF:Flavimonas oryzihabitans (Pseudomonas oryzihabitans, CDC group Ve-2) bacteremia in the immunocompromised host. Archives of Internal Medicine (1991) 151:603–604
Podbielski A, Mertens R, Ziebold C, Kaufhold A:Flavimonas oryzihabitans septicemia in a T-cell leukaemic child: a case report and review of literature. Journal of Infection (1990) 20:135–141
Couetdic G, Plesiat P, Chambers R, Cahn JY, Michel-Briand Y: Three cases of bacteremia with group Ve-2 bacteria in France. European Journal of Clinical Microbiology (1987) 6:499–500
Bending JW, Mayes PJ, Eyers DE, Holmes B, Chin TTL:Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2): an emerging pathogen in peritonitis related to continuous peritoneal dialvsis? Journal of Clinical Microbiology (1989) 27:217–218
Mutters R, Köppler H, Krause TH: Isolation ofFlavimonas oryzihabitans (CDC group Ve-2) from catheter-induced bacteremia in an immunocompromised patient. European Journal of Epidemiology (1990) 6:436–437
Reed RP:Flavimonas oryzihabitans sepsis in children. Clinical Infectious Diseases (1996) 22:733–734
Kiris S, Over U, Babacan F, Lawrence R, Korten V: DisseminatedFlavimonas oryzihabitans infection in a diabetic patient who presented with suspected multiple splenic abscesses. Clinical Infectious Diseases (1997) 25:324–325
Castagnola E, Conte M, Venzano P, Garaventa A, Viscoli C, Barretta VIA, Pescetto L, Tasso L, Nantron M, Milanaccio C, Giacchino R: Broviac catheter-related bacteraemias due to unusual pathogens in children with cancer: case reports and literature review. Journal of Infection (1997) 34:215–218
Lam S, Isenberg HD, Edwards B, Hilton E: Communityacquired soft-tissue infections caused byFlavimonas oryzihabitans. Clinical Infectious Diseases (1994) 18:808–809
Gilardi GL:Pseudomonas and related genera. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (eds): Manual of clinical microbiology. American Society for Microbiology, Washington DC (1991) pp. 429–441
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA (1993)
Lin RD, Hsueh PR, Chang JC, Teng LJ, Chang SC, Ho SW, Hsieh WC, Luh KT:Flavimonas oryzihabitans bacteremia: clinical features and microbiological characteristics of isolates. Clinical Infectious Diseases (1997) 24:867–873
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giacometti, A., Cirioni, O., Quarta, M. et al. Unusual clinical presentation of infection due toFlavimonas oryzihabitans . Eur. J. Clin. Microbiol. Infect. Dis. 17, 645–648 (1998). https://doi.org/10.1007/BF01708348
Issue Date:
DOI: https://doi.org/10.1007/BF01708348